Pimecrolimus

Back to search

Molecule Structure

Scientific Name

Pimecrolimus

Description of the Drug

Pimecrolimus is a topical calcineurin inhibitor used in the treatment of mild-moderate atopic dermatitis who are not candidates for other types of therapy due to previous lack of response or other reasons.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00337

Brand Name(s)

Elidel

Company Owner(s)

Glenmark Pharmaceuticals Ltd, Actavis Laboratories Ut Inc Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Bausch Health Us Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
FK506-binding protein 1A SINGLE PROTEIN INHIBITOR CHEMBL1902

Unichem Links

SureChEMBL SCHEMBL438880
DrugBank DB00337
PubChem: Thomson Pharma 14791428 14767061
PubChem 6509979
LINCS LSM-45937
BindingDB 50248356
DrugCentral 2168
ChemicalBook CB71086808
Guide to Pharmacology 6783
rxnorm PIMECROLIMUS ELIDEL
PubChem: Drugs of the Future 12014634
ChEBI 135888
ZINC ZINC000085536990